Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is uncle...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2022-06-01
|
Series: | The Journal of Pediatric Academy |
Subjects: | |
Online Access: | https://jpediatricacademy.com/index.php/jpa/article/view/182 |
_version_ | 1797767373252460544 |
---|---|
author | Benhur Sirvan Cetin Ayşenur Paç Kısaarslan Ali Baykan Başak Nur Akyıldız Hakan Poyrazoglu |
author_facet | Benhur Sirvan Cetin Ayşenur Paç Kısaarslan Ali Baykan Başak Nur Akyıldız Hakan Poyrazoglu |
author_sort | Benhur Sirvan Cetin |
collection | DOAJ |
description | Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to guide the evaluation of patients and management of those diagnosed with MIS-C. |
first_indexed | 2024-03-12T20:37:48Z |
format | Article |
id | doaj.art-0c150e7618924537b2779fc0f7e4c048 |
institution | Directory Open Access Journal |
issn | 2718-0875 |
language | English |
last_indexed | 2024-03-12T20:37:48Z |
publishDate | 2022-06-01 |
publisher | Galenos Publishing House |
record_format | Article |
series | The Journal of Pediatric Academy |
spelling | doaj.art-0c150e7618924537b2779fc0f7e4c0482023-08-01T11:23:16ZengGalenos Publishing HouseThe Journal of Pediatric Academy2718-08752022-06-0133879410.51271/jpea-2022-182132Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19Benhur Sirvan Cetin0https://orcid.org/0000-0002-8470-4907Ayşenur Paç KısaarslanAli BaykanBaşak Nur AkyıldızHakan PoyrazogluErciyes UniversityMultisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to guide the evaluation of patients and management of those diagnosed with MIS-C.https://jpediatricacademy.com/index.php/jpa/article/view/182covid-19mis-cguidelinepediatric |
spellingShingle | Benhur Sirvan Cetin Ayşenur Paç Kısaarslan Ali Baykan Başak Nur Akyıldız Hakan Poyrazoglu Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19 The Journal of Pediatric Academy covid-19 mis-c guideline pediatric |
title | Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19 |
title_full | Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19 |
title_fullStr | Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19 |
title_full_unstemmed | Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19 |
title_short | Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19 |
title_sort | erciyes clinical guideline for multisystem inflammatory syndrome in children mis c associated with covid 19 |
topic | covid-19 mis-c guideline pediatric |
url | https://jpediatricacademy.com/index.php/jpa/article/view/182 |
work_keys_str_mv | AT benhursirvancetin erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19 AT aysenurpackısaarslan erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19 AT alibaykan erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19 AT basaknurakyıldız erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19 AT hakanpoyrazoglu erciyesclinicalguidelineformultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19 |